Abstract
Transrectal microwave hyperthermia was applied to 46 stages D1 and D2 prostate cancer patients to treat urinary symptoms and local pain unrelieved by total androgen ablation therapy. Hyperthermia was administered in 10, 60- minute sessions twice a week for 5 weeks. A calculated intraprostatic temperature of 43.5 ± 0.5C was maintained throughout the treatment. At 2 years the mean residual urine volume was significantly decreased (p
| Original language | English |
|---|---|
| Pages (from-to) | 342-345 |
| Number of pages | 4 |
| Journal | Journal of Urology |
| Volume | 148 |
| Issue number | 2 I |
| Publication status | Published - 1992 |
Fingerprint
Keywords
- carcinoma
- hyperthermia, induced
- prostatic neoplasms
ASJC Scopus subject areas
- Urology
Cite this
Transrectal microwave hyperthermia for advanced prostate cancer : Long-term clinical results. / Montorsi, F.; Guazzoni, G.; Colombo, R.; Galli, L.; Bergamaschi, F.; Rigatti, P.
In: Journal of Urology, Vol. 148, No. 2 I, 1992, p. 342-345.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Transrectal microwave hyperthermia for advanced prostate cancer
T2 - Long-term clinical results
AU - Montorsi, F.
AU - Guazzoni, G.
AU - Colombo, R.
AU - Galli, L.
AU - Bergamaschi, F.
AU - Rigatti, P.
PY - 1992
Y1 - 1992
N2 - Transrectal microwave hyperthermia was applied to 46 stages D1 and D2 prostate cancer patients to treat urinary symptoms and local pain unrelieved by total androgen ablation therapy. Hyperthermia was administered in 10, 60- minute sessions twice a week for 5 weeks. A calculated intraprostatic temperature of 43.5 ± 0.5C was maintained throughout the treatment. At 2 years the mean residual urine volume was significantly decreased (p
AB - Transrectal microwave hyperthermia was applied to 46 stages D1 and D2 prostate cancer patients to treat urinary symptoms and local pain unrelieved by total androgen ablation therapy. Hyperthermia was administered in 10, 60- minute sessions twice a week for 5 weeks. A calculated intraprostatic temperature of 43.5 ± 0.5C was maintained throughout the treatment. At 2 years the mean residual urine volume was significantly decreased (p
KW - carcinoma
KW - hyperthermia, induced
KW - prostatic neoplasms
UR - http://www.scopus.com/inward/record.url?scp=0026673485&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026673485&partnerID=8YFLogxK
M3 - Article
C2 - 1378908
AN - SCOPUS:0026673485
VL - 148
SP - 342
EP - 345
JO - Journal of Urology
JF - Journal of Urology
SN - 0022-5347
IS - 2 I
ER -